Atb Cap Markets Weighs in on Organigram FY2027 Earnings

Organigram Holdings Inc. (NASDAQ:OGI) – Atb Cap Markets issued their FY2027 earnings per share estimates for Organigram in a research note issued on Tuesday, February 11th. Atb Cap Markets analyst F. Gomes expects that the company will post earnings per share of $0.06 for the year. The consensus estimate for Organigram’s current full-year earnings is ($0.09) per share. Atb Cap Markets also issued estimates for Organigram’s FY2028 earnings at $0.14 EPS.

Organigram (NASDAQ:OGI) last issued its quarterly earnings results on Tuesday, February 11th. The company reported ($0.05) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.02). Organigram had a negative net margin of 28.58% and a negative return on equity of 11.68%.

Organigram Price Performance

OGI stock opened at $1.36 on Thursday. The firm has a market cap of $170.95 million, a price-to-earnings ratio of -3.54 and a beta of 1.00. Organigram has a 1-year low of $1.29 and a 1-year high of $2.91. The firm has a fifty day moving average price of $1.56 and a two-hundred day moving average price of $1.67.

Institutional Investors Weigh In On Organigram

Institutional investors have recently modified their holdings of the business. Toronto Dominion Bank boosted its stake in Organigram by 803.7% in the third quarter. Toronto Dominion Bank now owns 16,727 shares of the company’s stock valued at $30,000 after acquiring an additional 14,876 shares during the period. Clear Harbor Asset Management LLC lifted its holdings in shares of Organigram by 37.4% in the 4th quarter. Clear Harbor Asset Management LLC now owns 45,000 shares of the company’s stock worth $72,000 after purchasing an additional 12,250 shares during the last quarter. Arrowstreet Capital Limited Partnership acquired a new position in Organigram during the 4th quarter valued at approximately $1,153,000. Finally, Tidal Investments LLC grew its stake in Organigram by 8.3% during the 3rd quarter. Tidal Investments LLC now owns 1,948,188 shares of the company’s stock worth $3,526,000 after buying an additional 149,171 shares during the last quarter. Institutional investors own 34.63% of the company’s stock.

Organigram Company Profile

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.